Takip et
Robert Gniadecki
Robert Gniadecki
Division of Dermatology, University of Alberta, Canada
ualberta.ca üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome–Update 2017
F Trautinger, J Eder, C Assaf, M Bagot, A Cozzio, R Dummer, R Gniadecki, ...
European journal of cancer 77, 57-74, 2017
5802017
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial
AB Kimball, F Kerdel, D Adams, U Mrowietz, JM Gelfand, R Gniadecki, ...
Annals of internal medicine 157 (12), 846-855, 2012
5372012
European consensus statement on phenotypes of pustular psoriasis
AA Navarini, AD Burden, F Capon, U Mrowietz, L Puig, S Köks, K Kingo, ...
Journal of the European Academy of Dermatology and Venereology 31 (11), 1792 …, 2017
5102017
Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and …
JJ Scarisbrick, HM Prince, MH Vermeer, P Quaglino, S Horwitz, P Porcu, ...
Journal of Clinical Oncology 33 (32), 3766-3773, 2015
4602015
Melanoma diagnosis by Raman spectroscopy and neural networks: structure alterations in proteins and lipids in intact cancer tissue
M Gniadecka, PA Philipsen, S Wessel, R Gniadecki, HC Wulf, ...
Journal of investigative dermatology 122 (2), 443-449, 2004
4502004
Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D
RG Erben, DW Soegiarto, K Weber, U Zeitz, M Lieberherr, R Gniadecki, ...
Molecular endocrinology 16 (7), 1524-1537, 2002
3582002
Comparison of long‐term drug survival and safety of biologic agents in patients with psoriasis vulgaris
R Gniadecki, B Bang, LE Bryld, L Iversen, S Lasthein, L Skov
British Journal of Dermatology 172 (1), 244-252, 2015
3312015
Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis
A Egeberg, MB Ottosen, R Gniadecki, S Broesby‐Olsen, TN Dam, ...
British Journal of Dermatology 178 (2), 509-519, 2018
3192018
Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
R Gniadecki, K Kragballe, TN Dam, L Skov
British Journal of Dermatology 164 (5), 1091-1096, 2011
3042011
Skin aging and natural photoprotection
HC Wulf, J Sandby-Møller, T Kobayasi, R Gniadecki
Micron 35 (3), 185-191, 2004
3042004
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)
U Ralfkiaer, PH Hagedorn, N Bangsgaard, MB Løvendorf, CB Ahler, ...
Blood, The Journal of the American Society of Hematology 118 (22), 5891-5900, 2011
2962011
Guidelines on the use of extracorporeal photopheresis
R Knobler, G Berlin, P Calzavara‐Pinton, H Greinix, P Jaksch, L Laroche, ...
Journal of the European Academy of Dermatology and Venereology 28, 1-37, 2014
2692014
Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma
YH Kim, M Duvic, E Obitz, R Gniadecki, L Iversen, A Österborg, ...
Blood, The Journal of the American Society of Hematology 109 (11), 4655-4662, 2007
2562007
Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti‐inflammatory drugs: a D anish real‐world cohort study
O Ahlehoff, L Skov, G Gislason, J Lindhardsen, SL Kristensen, L Iversen, ...
Journal of internal medicine 273 (2), 197-204, 2013
2292013
Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohort
O Ahlehoff, L Skov, G Gislason, R Gniadecki, L Iversen, LE Bryld, ...
Journal of the European Academy of Dermatology and Venereology 29 (6), 1128-1134, 2015
2222015
The optimal use of bexarotene in cutaneous T‐cell lymphoma
R Gniadecki, C Assaf, M Bagot, R Dummer, M Duvic, R Knobler, A Ranki, ...
British Journal of Dermatology 157 (3), 433-440, 2007
2022007
Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study
CC Zouboulis, MM Okun, EP Prens, R Gniadecki, PA Foley, C Lynde, ...
Journal of the American Academy of Dermatology 80 (1), 60-69. e2, 2019
1982019
Ultrasound structure and digital image analysis of the subepidermal low echogenic band in aged human skin: diurnal changes and interindividual variability
M Gniadecka, R Gniadecki, J Serup, J Søndergaard
Journal of investigative dermatology 102 (3), 362-365, 1994
1901994
Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis
SA Grando, JC Bystryn, AI Chernyavsky, M Frušić‐Zlotkin, R Gniadecki, ...
Experimental dermatology 18 (9), 764-770, 2009
1762009
Hydrogen peroxide is responsible for UVA-induced DNA damage measured by alkaline comet assay in HaCaT keratinocytes
AB Petersen, R Gniadecki, J Vicanova, T Thorn, HC Wulf
Journal of Photochemistry and Photobiology B: Biology 59 (1-3), 123-131, 2000
1762000
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20